Erdosteine
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Erdosteine is a mucolytic that is used in the treatment of respiratory tract disorders, characterized by productive cough.
Indications
Erdosteine is primarily indicated in conditions like Acute exacerbation of chronic bronchitis, and can also be given in adjunctive therapy as an alternative drug of choice in Respiratory tract disorders.
Contraindications
Erdosteine is contraindicated in conditions like Peptic ulcer, Liver damage, Hepatic cirrhosis with ascites.
Side Effects
The severe or irreversible adverse effects of Erdosteine, which give rise to further complications include LDL high. The signs and symptoms that are produced after the acute overdosage of Erdosteine include Flushing, Sweating, Vertigo. The symptomatic adverse reactions produced by Erdosteine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Urticaria, Erythema, Dermatitis, GIT effects, Taste alteration.
Warnings
The product in granulates (sachets and suspensions) contains sucrose, keep this into consideration in case of diabetes or low-calorie diets. Safety of Erdosteine in pregnancy has not been established and therefore as with all new drugs. Its use is not recommended. Also during lactation its use is not recommended. Keep out from children's reach. Kidney dysfunction and liver malfunction etc.
High Risk Groups
Drug should not be given to patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
150 to 300 mg (220 (225)) 8 hourly PO —
300 mg (300 (300)) 8 hourly PO — Patients should not exceed a dose of 300 mg per day.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Erdosteine was found.
Storage
caps Store in a well closed container, Below 20°C. Protect from Sunlight.
Available Brands in Pakistan
1 active brand listed alphabetically.
DOSTIN
ActiveBROOKES PHARMACEUTICAL LABORATORIES (PAK.) LTD.
DML: DOSTIN
CapsSuspSachet
2 additional records are present but flagged "Unverified / Legacy" and not listed.